Most Popular Stories
- Glaxo lays plans to pink-slip R&D workers
- Medivation's Dimebon turns in promising results for Huntington's
- BIO chief maps salvage plan for the 12-year umbrella
- Novartis licenses hep C drug from Debiopharm
- Amgen: Denosumab demonstrates superiority over Zometa
- Medivation's Dimebon turns in promising results for Huntington's
Webinars
- Clinical Trial Design 2010: How-to & What's New NEW SPEAKERS ANNOUNCED: Barbara Tardiff, Corporate Vice President of Data Sciences at Pare
- How to Land a Deal: Partnering with Big PharmaJoin FierceBiotech and speakers from GlaxoSmithKline, Millenium Takeda and Locust Walk Par
Featured Jobs
-
Business Development Director
Buckton Scott USA Inc. - Princeton, NJ -
Engineering Specialist
Baxter Healthcare - newport beach, CA -
Associate Director Medical Writing-MA
The Cambridge Group LTD - Westport -
VP Oncology Specialist, Medical Communications Agency, New York, NY
Summit Professional Search, Inc. - New York, NY -
Regional Deputy Director, Medical Science Liaisons, Women’sHealthCare Western US
Bayer - Wayne, NJ
Events
- DCAT Week 2010
Mar 15-18 — Waldorf-Astoria Hotel, New York City - 21st Annual Workshop on Medical Communications
March 14-17 — Scottsdale, A - Cyprotex 5th North American Drug Discovery Workshop
March 4th, 2010 — San Francisco, CA - R&D Operational Excellence Workshop
February 16th — Princeton, NJ
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 66,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Outsourcing Biomaterials Management – Preservation in a Downturn
- Webdevelopment best practices for biotech companies
- Taking a Commercial Approach to Drug Development - Target Product Profile Development and New Product Strategic Planning For Bio
- The Next Generation Life Sciences Executive: The 'F' Factors Necessary to Compete
- Patient Recruitment: Road to Success or Driving in Circles
- Don't Trust Your Gut, It Lies! The Value of an Opportunity Assessment Strategy
Ventana CEO Christopher Gleeson
